Literature DB >> 23774075

Women's knowledge and attitudes toward anal Pap testing.

Daron Ferris1, Rebecca Lambert, Jennifer Waller, Porscha Dickens, Reena Kabaria, Chi-Son Han, Charlotte Steelman, Fiyinfoluwa Fawole.   

Abstract

OBJECTIVE: The objectives of this study were to determine women's knowledge of human papillomavirus (HPV) and anal cancer and knowledge and attitudes toward the anal Pap test.
MATERIALS AND METHODS: A convenience sample of 370 women from the general population 21 years or older completed a 48-question preintervention survey; read an informational pamphlet about anal cancer, HPV, and anal Pap tests; and then completed a 21-question postintervention survey in Augusta, Atlanta, and Savannah, GA. The survey assessed their knowledge about anal cancer, HPV, and the anal Pap test and determined their attitudes toward the anal Pap test. Only preintervention results were considered in this article. Descriptive statistics were determined for all variables.
RESULTS: Only 17.6% of women had previously heard of anal Pap tests, and the majority knew nothing (48.9%) or only a little (38.5%) about anal cancer. Yet, most women (78.6%) knew that anal Pap tests help to prevent anal cancer, and 86.2% knew that anal Pap tests are not only for people who have anal sex. Only a minority of women recognized known risk factors for anal cancer. Lack of knowledge about anal Pap tests (43.8%), pain or discomfort (41.3%), cost (24.0%), and embarrassment (21.2%) were the main reasons cited for not wanting an anal Pap test.
CONCLUSIONS: Although most women had limited knowledge about anal cancer and anal Pap tests and few recognized known risk factors for anal cancer, women were receptive to screening. Further implementation of anal Pap testing for women may be improved by understanding women's limited knowledge and concerns.

Entities:  

Mesh:

Year:  2013        PMID: 23774075     DOI: 10.1097/LGT.0b013e3182760ad5

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  6 in total

1.  Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

Authors:  L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

2.  Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.

Authors:  Beth Cronin; Amy Bregar; Christine Luis; Steven Schechter; Paul Disilvestro; Latha Pisharodi; C James Sung; Christina Raker; Melissa Clark; Katina Robison
Journal:  Gynecol Oncol       Date:  2016-04-26       Impact factor: 5.482

Review 3.  Anal cancer and intraepithelial neoplasia screening: A review.

Authors:  Ira L Leeds; Sandy H Fang
Journal:  World J Gastrointest Surg       Date:  2016-01-27

4.  Acceptability of anal cancer screening tests for women living with HIV in the EVVA study.

Authors:  E Kaufman; C de Castro; T Williamson; B Lessard; M Munoz; M H Mayrand; A N Burchell; M B Klein; L Charest; M Auger; V Marcus; F Coutlée; A de Pokomandy
Journal:  Curr Oncol       Date:  2020-02-01       Impact factor: 3.677

5.  Knowledge, Attitudes, and Experiences of Anal Cancer and Anal Cancer Screening Among a Clinical Sample of Hispanic Women.

Authors:  Ana P Ortiz; Sandra I García-Camacho; Jeslie M Ramos-Cartagena; Vivian Colón-López; Lianeris M Estremera-Rodríguez; Kyara M Berríos-Toledo; Josefina Romaguera
Journal:  J Low Genit Tract Dis       Date:  2021-04-01       Impact factor: 1.925

6.  Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV.

Authors:  Serena A Rodriguez; Robin T Higashi; Andrea C Betts; Cynthia Ortiz; Jasmin A Tiro; Amneris E Luque; Arti Barnes
Journal:  J Low Genit Tract Dis       Date:  2021-01-01       Impact factor: 3.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.